• home
  • ABOUT
    • company profile
    • Strategy
    • Management Team & Board Of Directors
  • Products
    • PRF-110
    • Product Pipeline
    • Clinical Trials
  • Market
  • Investors
    • press releases
      • sec filling
    • presentations
    • from the press
    • governance
  • Contact
Menu
  • home
  • ABOUT
    • company profile
    • Strategy
    • Management Team & Board Of Directors
  • Products
    • PRF-110
    • Product Pipeline
    • Clinical Trials
  • Market
  • Investors
    • press releases
      • sec filling
    • presentations
    • from the press
    • governance
  • Contact

Archives: from-the-press

PainReform raised $ 20 million in initial public offering on NASDAQ

$ 15 million and final stage in painkiller trial in Painreform

© 2021 PainReform

Privacy Policy

Terms of Use

this site made by